Proteolysis‐targeting chimeras in antiviral therapy: Leveraging influenza virus and exosome‐mediated delivery for targeted protein degradation and therapeutic advancements

The authors declare no conflict of interest. Data sharing is not applicable to this article as no new data were created or analyzed in this study.